Page 3 - Small Cap Australian (ASX) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
CTE Cryosite	AU$0.90	1.7%	38.8%	AU$43.7m	n/a	PE23.7x	n/a	2.2%
MVP Medical Developments International	AU$0.42	-5.6%	-46.8%	AU$47.3m	AU$2.94	PS1.4x	E93.1%	0%
SPL Starpharma Holdings	AU$0.12	9.5%	-17.9%	AU$48.0m	n/a	PS4.9x	n/a	n/a
RAD Radiopharm Theranostics	AU$0.025	0%	-65.3%	AU$54.3m	n/a	PS27.7x	E10.9%	n/a
VIT Vitura Health	AU$0.098	4.3%	-68.9%	AU$57.0m	n/a	PE16.2x	n/a	0%
TYP Tryptamine Therapeutics	AU$0.045	-8.2%	n/a	AU$57.4m	n/a	PS43.3x	n/a	n/a
SNT Syntara	AU$0.046	9.5%	43.8%	AU$63.2m	n/a	PS11x	E43.7%	n/a
ACW Actinogen Medical	AU$0.026	13.0%	18.2%	AU$76.6m	n/a	PS7.7x	E-22.1%	n/a
BTG Beroni Group	AU$0.99	0%	n/a	AU$75.9m	n/a	PS39.8x	n/a	n/a
PER Percheron Therapeutics	AU$0.074	-6.3%	23.3%	AU$78.4m	n/a	PS26.4x	E19.8%	n/a
PIQ Proteomics International Laboratories	AU$0.66	-7.1%	-29.9%	AU$85.8m	n/a	PS26.2x	E28.8%	n/a
AGN Argenica Therapeutics	AU$0.72	-4.0%	65.5%	AU$92.2m	n/a	PS35.5x	n/a	n/a
NUZ Neurizon Therapeutics	AU$0.19	-5.0%	131.7%	AU$92.5m	n/a	PS109.8x	S58.2%	n/a
RCE Recce Pharmaceuticals	AU$0.46	-8.0%	5.7%	AU$106.7m	AU$2.46	PS21.2x	E-51.3%	n/a
PAR Paradigm Biopharmaceuticals	AU$0.33	35.4%	-14.5%	AU$113.9m	n/a	PB4.8x	E8.8%	n/a
EZZ EZZ Life Science Holdings	AU$2.61	-11.5%	321.0%	AU$115.9m	AU$5.45	PE16.6x	E17.9%	1.1%
VLS Vita Life Sciences	AU$2.08	0.5%	20.6%	AU$117.1m	n/a	PE12.5x	n/a	4.3%
OCC Orthocell	AU$0.61	-1.6%	51.9%	AU$147.1m	n/a	PS27.7x	n/a	n/a
TRJ Trajan Group Holdings	AU$0.97	-13.7%	-22.0%	AU$148.5m	AU$1.40	PB1.4x	E99.2%	n/a
GSS Genetic Signatures	AU$0.70	1.4%	41.4%	AU$158.8m	AU$1.10	PS11.5x	E98.6%	n/a
LTP LTR Pharma	AU$1.22	-8.0%	n/a	AU$186.9m	n/a	PS3813.6x	n/a	n/a
DXB Dimerix	AU$0.34	-8.0%	155.6%	AU$192.5m	n/a	PS329.8x	n/a	n/a
ALA Arovella Therapeutics	AU$0.19	-7.3%	120.9%	AU$200.5m	n/a	PS102.7x	n/a	n/a
ARX Aroa Biosurgery	AU$0.66	4.0%	-2.2%	AU$225.9m	n/a	PS3.6x	E56.3%	n/a